ERBB2 and breast carcinoma: Our SP-IRIS analysis of exosomes derived from breast cancer cell lines revealed distinct patterns of HER2 and tetraspanin expression, contributing to the growing body of knowledge on exosome heterogeneity and their potential as biomarkers.